Accès ouvert
2026
article
OpenAlex
Amir Roshanzadeh, Hyllana C. D. Medeiros, Tessa Jordan, Carson Malhado et autres
Abstract Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat without substantial functional and cosmetic morbidity, as current management relies largely on surgery, radiation, and chemotherapy. However, these approaches often fail to achieve effective tumor control in therapy-resistant HNSCC. Photodynamic …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Amir Roshanzadeh, Hyllana C. D. Medeiros, Christopher K. Herrera, Carson Malhado et autres
Abstract Photodynamic therapy (PDT) has emerged as a promising targeted treatment for cancer. However, current PDT is limited by low tissue penetration, insufficient phototoxicity (toxicity with light irradiation), and undesirable cytotoxicity (toxicity without light irradiation). Here, we report the discovery of cyanine‐carborane …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Amir Roshanzadeh, Hyllana C. D. Medeiros, Christopher K. Herrera, Carson Malhado et autres
Abstract Photodynamic therapy (PDT) has emerged as a promising targeted treatment for cancer. However, current PDT is limited by low tissue penetration, insufficient phototoxicity (toxicity with light irradiation), and undesirable cytotoxicity (toxicity without light irradiation). Here, we report the discovery of cyanine‐carborane …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Hyllana C. D. Medeiros, Sophia Y. Lunt
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Elliot Ensink, Tessa Jordan, Hyllana C. D. Medeiros, Galloway Thurston et autres
Abstract Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with high mortality and limited efficacious therapeutic options. PDAC cells undergo metabolic alterations to survive within a nutrient-depleted tumor microenvironment. One critical metabolic shift in PDAC cells occurs through altered isoform expression of …
us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C. D. Medeiros, Elliot Ensink et autres
Anti-hormone therapies are not efficacious for reducing the incidence of triple negative breast cancer (TNBC), which lacks both estrogen and progesterone receptors. While the etiology of this aggressive breast cancer subtype is unclear, visceral obesity is a strong risk factor for both …
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Jonathan D. Diedrich, Romina Gonzalez-Pons, Hyllana C. D. Medeiros, Elliot Ensink et autres
us
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Elliot Ensink, Tessa Jordan, Hyllana C. D. Medeiros, Galloway Thurston et autres
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Deanna Broadwater, Hyllana C. D. Medeiros, Matthew Bates, Amir Roshanzadeh et autres
High Resolution Image Download MS PowerPoint Slide Photodynamic therapy (PDT) has the potential to improve cancer treatment by providing dual selectivity through the use of both photoactive agent and light, with the goal of minimal harmful effects from either the agent or …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hyllana C. D. Medeiros, Chenchen Yang, Christopher K. Herrera, Deanna Broadwater et autres
Photodynamic therapy (PDT) is currently limited by the inability of photosensitizers (PSs) to enter cancer cells and generate sufficient reactive oxygen species. Utilizing phosphorescent triplet states of novel PSs to generate singlet oxygen offers exciting possibilities for PDT. Here, we report phosphorescent …
us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Hyllana C. D. Medeiros, Sophia Y. Lunt
us
(code pays fourni par la source)
Accès ouvert
2021
review
OpenAlex
Deanna Broadwater, Hyllana C. D. Medeiros, Richard R. Lunt, Sophia Y. Lunt
Photoactive agents are promising complements for both early diagnosis and targeted treatment of cancer. The dual combination of diagnostics and therapeutics is known as theranostics. Photoactive theranostic agents are activated by a specific wavelength of light and emit another wavelength, which can …
us
(code pays fourni par la source)